Description
RxLink Crave Control Nutritional Support for Neurotransmitter Balance
DESCRIPTION
RxLink Crave Control supports the synthesis of the brain reward neurotransmitters (like serotonin and catecholamines) and through its effect on the natural opioids will, by virtue of inhibiting GABA, cause a significant release of dopamine at the nucleus accumbens. This constant release of possibly therapeutic amounts of dopamine, leads to proliferation of D2 receptors, thereby promoting appetite suppression and reducing overall craving in general.
FUNCTIONS
Early biochemical textbooks reference certain carboxypeptidase inhibitors, of which one of the most potent amino acids included was D-Phenylalanine. Years later, studies of D-Phenylalanine demonstrated three important roles for the amino acid; analgesic, anti-inflammatory and anti-craving. Further studies revealed that certain enzymes were responsible for the breakdown of brain opioid peptides. Brain studies indicated that D-Phenylalanine inhibited the enzyme, enkephalinase. Injections of D-Phenylalanine resulted in inhibition of enkephalinase and higher levels of the brain opioid enkephalin. While D-Phenylalanine alone is considered a drug, DL-Phenylalanine, which is in Crave Control, is considered a neutraceutical, and is as effective as D-Phenylalanine, only at a slightly higher dose.
Further studies have demonstrated that low dopamine D2 receptors and/or low amounts of dopamine released at the synapse in the brain, will lead to craving behavior. It is further understood that if D2 receptors are continually stimulated, a positive feedback will induce the development of additional D2 receptors. Therefore, if D2 receptors are compromised in the human, then stimulating D2 receptors with dopamine will reduce craving behavior. Anti-craving behavior can be induced if there is a means of continually releasing dopamine at the reward site of the brain in the mesolimbic system, and even in a genetically compromised individual, existing craving behavior can be improved.
In addition to DL-Phenylalanine, Crave Control contains the necessary ingredients to properly utilize DL-Phenylalanine and increase dopamine production. Ingredients such as L-Tyrosine, L-Glutamine, 5-HTP, Rhodiola Rosea and P5P help to ensure that healthy levels of dopamine are encouraged to address “Reward Deficiency Syndrome” which features multiple expressions including overeating and carbohydrate binging. In conclusion,
RxLink Crave Control causes the synthesis of the brain reward neurotransmitters such as serotonin and catecholamines. And through its effect on natural opioids, will by inhibiting GABA, cause a significant release of dopamine at the nucleus accumbens. This release of increased amounts of dopamine creates a proliferation of D2 receptors, thereby reducing cravings for carbohydrates. This same improvement in the craving process can also be approached in other behaviors where craving is a major concern.
INDICATIONS
RxLink Crave Control may be a useful dietary supplement in individuals who exhibit dopamine deficient cravings or who are attempting to increase their D2 receptors and dopamine levels in the brain.
FORMULA (WW #RxLink10344) Eight Capsules Contain:
Vitamin C (ascorbic acid) …………………………..600 mg
Vitamin B6 (as pyridxoal-5-phosphate) ………50 mg
Folic Acid ……………………………………………….400 mcg
Calcium (from calcium citrate) …………………168 mg
Magnesium (from magnesium citrate) ……….150 mg
Chromium (from chromium picolinate) ……….1 mg
DL-Phenylalanine ……………………………………………2 g L-Tyrosine ……………………………………………………1.5 g L-Glutamine ……………………………………………..750 mg
Rhodiola rosea Root Extract ……………………….200 mg
[standardized to 3:1 ratio of 3% rosavins and 1% salidrosides]
L-5-Hydroxytryptophane (L-5-HTP) ……………150 mg
Other Ingredients: Gelatin (capsule), magnesium stearate, and silicon dioxide.
SUGGESTED USE
As a dietary supplement, adults take 6-12 capsules per day, 45 minutes before meals, or as directed by a healthcare professional.
STORAGE Store in a cool, dry place, away from direct light. Keep out of reach of children. WARNING If you are nursing, pregnant, or taking other medications, consult your healthcare professional before use.
RxLink Crave Control Nutritional Support for Neurotransmitter Balance
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
